Flu News Friday, 4/15/2022
Read the latest on influenza vaccines and upcoming funding opportunities in this week’s roundup.
Call to Action for World Leaders: Accelerating an Effective and Equitable COVID-19 Response and Pandemic-proofing the Future
Pandemic Action Network, March 25, 2022
The pandemic isn’t over- only 14% of everyone living in low-income countries have received at least one dose of a COVID-19 vaccine. To protect against deadly variants, the Pandemic Action Network and more than 35 endorsing organizations have called on G7 and G20 leaders to invest towards ending this pandemic and preventing the next one. Read the call to strengthen pandemic preparedness systems, diversify funding to address gaps in preparedness, and increase equitable availability of vaccines, diagnostics and therapeutics here.
Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination
Dhanasekaran, V., Sullivan, S., Edwards, K.M. et al. (2022). Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun 13(1721).
As lack of exposure to influenza reduces population immunity, future seasonal influenza outbreaks may be more severe than those prior to the COVID-19 pandemic. During the 2020-2021 influenza season, lineages such as B/Yamagata largely disappeared due to low influenza infection rates. However, waning COVID-19 preventative measures and regional vaccine inequities will likely enable many influenza strains to re-emerge, making continued surveillance essential. Learn where influenza was detected during the 2020-2021 influenza season and the history of influenza circulation here.
New crop of covid-19 mrna vaccines could be easier to store, cheaper to use
Cohen, J. (2022, April 5). New crop of covid-19 mrna vaccines could be easier to store, cheaper to use. Science.
More than 15 new COVID-19 mRNA vaccines are advancing into clinical studies, many of which would be easier to store and lower in price than the first generation of COVID-19 mRNA vaccines. While clinical studies are challenging due to ethical concerns and low levels of an unexposed public, these vaccines could dramatically increase global access to mRNA technology. Read more about these promising candidates here.
Applications Close April 15, 2022 for the 4th International Workshop on Participatory Surveillance
Applications for the 4th International Workshop on Participatory Surveillance (IWOPS) close April 15th– today! This workshop hosted by Ending Pandemics will be held in Phnom Penh, Cambodia from October 31-November 3, 2022 and will convene global experts to establish data standards, integrate new technologies, explore disease modeling and more. To participate in improving community engagement towards human, animal and environmental health globally, apply here.
Funding Opportunities & Announcements
Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India (Link) [Discretionary Grant] CDC-ERA / March 8, 2022 / May 4, 2022
US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings (Link) [Discretionary Grant] CDC- ERA / March 17, 2022 / May 9, 2022
Postdoctoral Clinical Fellows (Link) [Fellowship] The Francis Crick Institute / March 14, 2022 / April 29, 2022
Tribal Epidemiology Centers Public Health Infrastructure (Link) [Discretionary Grant] CDC- NCCDPHP / April 5, 2022 / May 11, 2022
Apply for Mini-Funds to Encourage Open Science Practices in Influenza Research [Link] [Grants] Center for Open Science and Flu Lab / Open